Visa Inc. Fiscal Third Quarter 2021 Financial Results
Get Alerts V Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.9%
EPS Growth %: +8.1%
Join SI Premium – FREE
SAN FRANCISCO--(BUSINESS WIRE)-- Visa Inc. (NYSE: V) today announced its fiscal third quarter 2021 financial results through an earnings release that will be furnished with the Securities and Exchange Commission on a Form 8-K and will be available on its Investor Relations website at http://investor.visa.com/sec-filings/default.aspx.
Visa will host a live audio webcast at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss these financial results. The webcast and all related materials can also be accessed through Visa’s Investor Relations website at http://investor.visa.com/financial-information/quarterly-earnings/default.aspx.
About Visa Inc.
Visa Inc. (NYSE: V) is the world’s leader in digital payments. Our mission is to connect the world through the most innovative, reliable and secure payment network – enabling individuals, businesses and economies to thrive. Our advanced global processing network, VisaNet, provides secure and reliable payments around the world, and is capable of handling more than 65,000 transaction messages a second. The company’s relentless focus on innovation is a catalyst for the rapid growth of digital commerce on any device for everyone, everywhere. As the world moves from analog to digital, Visa is applying our brand, products, people, network and scale to reshape the future of commerce. For more information, visit About Visa, visa.com/blog and @VisaNews.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210727006134/en/
Investor Relations: Mike Milotich or Jennifer Como, 650-432-7644, [email protected]
Media Relations: Andy Gerlt, 650-432-2990, [email protected]
Source: Visa Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- CVG to join Russell 2000 and Russell 3000 indexes June 26
- Silexion gets German approval for pancreatic cancer trial of SIL204
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share